share_log

Pyxis Oncology FY EPS $(1.85) Beats $(1.95) Estimate; Cash And Cash Equivalents Of $120.8M And Gross Procced Of $10.8M and $50M Via ATM Offering And Private Placement Is Expected To Provide Cash Runway Into 2H 2026

Moomoo 24/7 ·  Mar 21 07:41

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(1.85) per share which beat the analyst consensus estimate of $(1.95) by 5.13 percent. This is a 49.32 percent increase over losses of $(3.65) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment